Treating colonic diverticula with rifaximin: a call to action

go back to reference Tursi A, Brandimarte G, Di Mario F, Lanas A, Scarpignato C, Bafutto M, Barbara G, Bassotti G, Binda GA, Biondi A, Biondo S, Cambiè G, Cassieri C, Crucitti A, Dumitrascu DL, Elisei W, Escalante R, Herszènyi L, Kruis W, Kupcinskas J, Lahat A, Lecca PG, Maconi G, Malfertheiner P, Mazzari A, Mearìn F, Milosavljeviċ T, Nardone G, Chavez De Oliveira E, Papa A, Papagrigoriadis S, Pera M, Persiani R, Picchio M, Regula J, Štimac D, Stollman N, Strate LL, Violi A, Walker MM (2019) International consensus on diverticulosis and diverticular disease. statements from the 3rd international symposium on diverticular disease. J Gastrointestin Liver Dis 28:57–66CrossRefPubMed Tursi A, Brandimarte G, Di Mario F, Lanas A, Scarpignato C, Bafutto M, Barbara G, Bassotti G, Binda GA, Biondi A, Biondo S, Cambiè G, Cassieri C, Crucitti A, Dumitrascu DL, Elisei W, Escalante R, Herszènyi L, Kruis W, Kupcinskas J, Lahat A, Lecca PG, Maconi G, Malfertheiner P, Mazzari A, Mearìn F, Milosavljeviċ T, Nardone G, Chavez De Oliveira E, Papa A, Papagrigoriadis S, Pera M, Persiani R, Picchio M, Regula J, Štimac D, Stollman N, Strate LL, Violi A, Walker MM (2019) International consensus on diverticulosis and diverticular disease. statements from the 3rd international symposium on diverticular disease. J Gastrointestin Liver Dis 28:57–66CrossRefPubMed

go back to reference Tursi A, Scarpignato C, Strate LL, Lanas A, Kruis W, Lahat A, Danese S (2020) Colonic diverticular disease. Erratum. In: Nat Rev Dis Primers. 6(1):20 Tursi A, Scarpignato C, Strate LL, Lanas A, Kruis W, Lahat A, Danese S (2020) Colonic diverticular disease. Erratum. In: Nat Rev Dis Primers. 6(1):20

go back to reference Piccin A, Gulotta M, di Bella S, Martingano P, Crocè LS, Giuffrè M (2023) Diverticular disease and rifaximin: an evidence-based review. Antibiotics (Basel) 12(3):443CrossRefPubMed Piccin A, Gulotta M, di Bella S, Martingano P, Crocè LS, Giuffrè M (2023) Diverticular disease and rifaximin: an evidence-based review. Antibiotics (Basel) 12(3):443CrossRefPubMed

go back to reference Gatta L, Bellini M, Scarpignato C, Marrocco W, Chiriatti A, Grosso A, Lambiase C, Usai-Satta P, Vassallo R, Bartoletti P, Minica F, Manta R, Scotti S, Soncini M (2024) Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners. Intern Emerg Med https://doi.org/10.1007/s11739-024-03597-5 Gatta L, Bellini M, Scarpignato C, Marrocco W, Chiriatti A, Grosso A, Lambiase C, Usai-Satta P, Vassallo R, Bartoletti P, Minica F, Manta R, Scotti S, Soncini M (2024) Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners. Intern Emerg Med https://​doi.​org/​10.​1007/​s11739-024-03597-5

go back to reference Cuomo R, Barbara G, Annibale B (2017) Rifaximin and diverticular disease: position paper of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 49:595–603CrossRefPubMed Cuomo R, Barbara G, Annibale B (2017) Rifaximin and diverticular disease: position paper of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 49:595–603CrossRefPubMed